Liposomal doxorubicin is a form of the chemotherapy drug doxorubicin that is encapsulated within nanoscale lipid bilayers called liposomes. This formulation is designed to enhance the drug's delivery to cancer cells while minimizing its toxic effects on healthy tissues. The use of liposomes as a delivery system is a significant advancement in the field of nanotechnology.
